Seners et al. JAMA Neurol. 2021


Prediction of Early Neurological Deterioration in Individuals With Minor Stroke and Large Vessel Occlusion Intended for Intravenous Thrombolysis Alone.  Seners P, Ben Hassen W, Lapergue B, Arquizan C, Heldner MR, Henon H, Perrin C, Strambo D, Cottier JP, Sablot D, Girard Buttaz I, Tamazyan R, Preterre C, Agius P, Laksiri N, Mechtouff L, Béjot Y, Duong DL, Mounier-Vehier F, Mione G, Rosso C, Lucas L, Papassin J, Aignatoaie A, Triquenot A, Carrera E, Niclot P, Obadia A, Lyoubi A, Garnier P, Crainic N, Wolff V, Tracol C, Philippeau F, Lamy C, Soize S, Baron JC, Turc G. JAMA Neurol. 2021 Jan 11;. doi: 10.1001/jamaneurol.2020.4557. [Epub ahead of print] PubMed PMID: 33427887. Download from HAL-INSERM

 

Cet article est issu de la cohorte multicentrique MINOR-STROKE que Pierre et moi coordonnons. Il étudie la détérioration neurologique précoce post-thrombolyse intraveineuse chez les patients présentant un déficit neurologique mineur et une occlusion proximale, et montre les résultats suivants : 

              1) 13% des patients présentent une détérioration neurologique précoce, qui est d’origine « ischémique » dans 90% des cas (très rares aggravations hémorragiques dans cette population)

              2) Cette détérioration neurologique « ischémique » est très fortement associée à un mauvais pronostic à 3mois, y compris en cas de thrombectomie « de sauvetage »

              3) Les 2 seuls facteurs prédictifs indépendants de détérioration neurologique identifiés sont le site de l’occlusion artérielle et la longueur du thrombus (à savoir, les marqueurs de non-recanalisation post-thrombolyse)

              4) Un score prédictif d’aggravation clinique, basé sur ces 2 variables, permet une prédiction satisfaisante de cette aggravation, sur 2 larges cohortes indépendantes.

 

Abstract

Importance: The best reperfusion strategy in patients with acute minor stroke and large vessel occlusion (LVO) is unknown. Accurately predicting early neurological deterioration of presumed ischemic origin (ENDi) following intravenous thrombolysis (IVT) in this population may help to select candidates for immediate transfer for additional thrombectomy.

Objective: To develop and validate an easily applicable predictive score of ENDi following IVT in patients with minor stroke and LVO.

Design, setting, and participants: This multicentric retrospective cohort included 729 consecutive patients with minor stroke (National Institutes of Health Stroke Scale [NIHSS] score of 5 or less) and LVO (basilar artery, internal carotid artery, first [M1] or second [M2] segment of middle cerebral artery) intended for IVT alone in 45 French stroke centers, ie, including those who eventually received rescue thrombectomy because of ENDi. For external validation, another cohort of 347 patients with similar inclusion criteria was collected from 9 additional centers. Data were collected from January 2018 to September 2019.

Main outcomes and measures: ENDi, defined as 4 or more points' deterioration on NIHSS score within the first 24 hours without parenchymal hemorrhage on follow-up imaging or another identified cause.

Results: Of the 729 patients in the derivation cohort, 335 (46.0%) were male, and the mean (SD) age was 70 (15) years; of the 347 patients in the validation cohort, 190 (54.8%) were male, and the mean (SD) age was 69 (15) years. In the derivation cohort, the median (interquartile range) NIHSS score was 3 (1-4), and the occlusion site was the internal carotid artery in 97 patients (13.3%), M1 in 207 (28.4%), M2 in 395 (54.2%), and basilar artery in 30 (4.1%). ENDi occurred in 88 patients (12.1%; 95% CI, 9.7-14.4) and was strongly associated with poorer 3-month outcomes, even in patients who underwent rescue thrombectomy. In multivariable analysis, a more proximal occlusion site and a longer thrombus were independently associated with ENDi. A 4-point score derived from these variables-1 point for thrombus length and 3 points for occlusion site-showed good discriminative power for ENDi (C statistic = 0.76; 95% CI, 0.70-0.82) and was successfully validated in the validation cohort (ENDi rate, 11.0% [38 of 347]; C statistic = 0.78; 95% CI, 0.70-0.86). In both cohorts, ENDi probability was approximately 3%, 7%, 20%, and 35% for scores of 0, 1, 2 and 3 to 4, respectively.

Conclusions and relevance: The substantial ENDi rates observed in these cohorts highlights the current debate regarding whether to directly transfer patients with IVT-treated minor stroke and LVO for additional thrombectomy. Based on the strong associations observed, an easily applicable score for ENDi risk prediction that may assist decision-making was derived and externally validated.

This part of the website could either be in French or English, depending on the sources of the actualities.

SIDEBAR_ARCHIVE_TITLE

 01 juillet 2022
Cortical wiring by synapsespecific control of local protein synthesis
 03 juin 2022
Programming neural cells for disease modelling and therapy development
 06 mai 2022
Phenomenology and pathophysiology of antipsychotic-induced compulsive behaviour
 01 avril 2022
Medial Septum cholinergic inputs to CA2: a new role in social novelty discrimination
 04 mars 2022
Molecular Dissection of Selective Neuronal Vulnerability in Alzheimer's Disease
 04 février 2022
Quantitative analysis and modelling of dendrite growth
 07 janvier 2022
Neurobiology of social and non social decision-making processes in mouse models
 21 décembre 2021 31 décembre 2021
Psychiatry and Neuroscience Seminar Series 2021
 03 décembre 2021
Deconstructing the role of dopamine signaling in defensive behaviors
 05 novembre 2021
Molecular mechanisms of synaptic development: insights from a human-specific gene
 01 octobre 2021
Implementing motor learning in stroke neurorehabilitation
 03 septembre 2021
Neurodegenerative diseases in the age of genetic engineering
 02 juillet 2021
From neuro-development to pediatric cancers: physiological and pathological contributions of axon guidance gene pathways
 04 juin 2021
Sexual signaling in wild house mice
 07 mai 2021
The axonal cytoskeleton at the nanoscale
 22 avril 2021
Dabertrand et al. Proc Natl Acad Sci U S A. 2021
 22 avril 2021
Duriez et al.  Eur Eat Disord Rev. 2021 Apr 14;. doi: 10.1002/erv.2829. [Epub ahead of print] PubMed PMID: 33851482
 20 avril 2021
Rebholz et al. Am J Otolaryngol. 2021
 12 avril 2021
Une équipe et quatre projets contre les AVC
 05 mars 2021
Feeding behavior in preclinical models of obesity